BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 yearsNazneen Rahman, Margaret Warren-Perry, Deborah Hughes et al.|British Journal of Cancer|2012Cited by 98
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Rosalind A. Eeles, Emma Killick et al.|Familial Cancer|2017Cited by 68